Purchase Order HHSN268201300091P
Award Date 3/27/13
Potential Completion Date 4/2/18
Potential Value $143K
Federal Agency
Ultimate Awardee
NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Heart Lung and Blood Institute issued a delivery order to Becton, Dickinson And Company (BD Biosciences division) on October 19, 2012, with a ceiling value of $32,485.20 for service and maintenance of a four-laser flow cytometry instrument (model Fortessa, serial H79900001) located in Bethesda, Maryland. The order ran from December 1, 2012 through November 30, 2013 under firm fixed price terms. Work was performed at the National Heart Lung and Blood Institute facility in Bethesda,...
- The National Heart Lung and Blood Institute awarded a purchase order to Becton, Dickinson and Company (BD Biosciences) for $29,795.40 on January 23, 2019, for a maintenance agreement with an ultimate completion date of January 31, 2020. Work is performed at Bethesda, Maryland. The order is firm fixed price with no small business set-aside applied. The maintenance agreement supports BD flow cytometry instrumentation operated by the Institute, consistent with BD Biosciences' established supplier...
- <p>The National Heart Lung and Blood Institute issued a delivery order to Becton, Dickinson And Company (BD Biosciences division) on November 20, 2015, with a ceiling value of $11,756.40 for renewal of a maintenance agreement for a flow cytometer machine.</p> <p>Place of performance is Bethesda, Maryland. The order is firm fixed price with an ultimate completion date of November 14, 2016. No set-aside was used.</p>
- The National Heart Lung and Blood Institute awarded a purchase order to Becton, Dickinson And Company (BD Biosciences division) for $29,376.00 on February 10, 2015, with an ultimate completion date of March 14, 2016. The order covers a FACSARIA II special order system maintenance agreement, priced on a firm fixed price basis with no set-aside. Work is performed at Bethesda, Maryland. This is a commercial item procurement for flow cytometry system maintenance, consistent with BD Biosciences'...
- <p>The National Heart Lung and Blood Institute issued a purchase order to Becton, Dickinson and Company (Infectious Disease Systems division) on February 28, 2018, with a ceiling value of $32,562.00 for maintenance services. The order is firm fixed price with no small business set-aside. Place of performance is Bethesda, Maryland. The ultimate completion date is March 14, 2019.</p>
- The National Heart Lung and Blood Institute awarded a purchase order to Becton, Dickinson and Company (BD Biosciences) for an LSRFortessa multi-year maintenance agreement with a ceiling value of $283,987.80, awarded November 17, 2014, with ultimate completion November 20, 2019. Place of performance is Bethesda, Maryland. The order is firm fixed price with no set-aside. This is a maintenance agreement supporting flow cytometry instrumentation at a federal research facility, typical of BD...
- <p>The National Heart Lung and Blood Institute awarded a purchase order to Becton, Dickinson And Company's BD Biosciences division valued at $29,828.40 for maintenance agreement services on a BD Biosciences LSR Fortessa special order system, with an award date of January 7, 2015 and ultimate completion date of January 31, 2016.</p> <p>Work is performed in Bethesda, Maryland. The purchase order carries firm fixed price terms and no set-aside designation.</p>
- <p>The National Heart Lung and Blood Institute awarded a purchase order to Becton, Dickinson And Company (BD Biosciences division) on December 20, 2016, with a ceiling value of $29,795.40 for maintenance services. The order is firm fixed price with no set-aside. Place of performance is Bethesda, Maryland. Ultimate completion date is January 31, 2018.</p>
- <p>The National Heart Lung and Blood Institute issued a delivery order to Becton, Dickinson And Company (BD Biosciences division) on October 15, 2010, with a ceiling value of $13,579.92.</p> <p>The order runs through September 30, 2011, and is priced as firm fixed price with no set-aside applied. Place of performance is Bethesda, MD 20892.</p>
- The National Heart Lung and Blood Institute issued a delivery order to Becton, Dickinson And Company on October 19, 2015, with a ceiling value of $13,214.40 and ultimate completion date of November 17, 2016. Place of performance is Bethesda, MD. The order was issued under full-and-open competition with no set-aside. The requirement covers laboratory and diagnostic supplies or equipment within Becton, Dickinson And Company's BD Biosciences division portfolio of flow cytometry instrumentation,...
The National Heart Lung and Blood Institute awarded a purchase order to Becton, Dickinson and Company for $142,981.11 on March 27, 2013, for service on an LSR II Special flow cytometer system (no lasers). Performance is located in Bethesda, Maryland. The order is firm fixed price with an ultimate completion date of April 2, 2018.
Generated 6/1/26, 10:51 AM
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Intent to Sole Source to Becton, Dickinson and Company (BD Biosciences) for Preventative Maintenance Services for the BD Biosciences Flow Cytometer Analyzer; Lasers; and High Throughput Sampler | NHLBI-CSB-HL-2013-106-RRJ | Department of Health and Human Services National Institutes of Health | Award Notice 1/1 | 3/1/13, 3:02 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00010 | Other Administrative Action | ($3) | 4/12/22 | |
| P00009 | Other Administrative Action | ($33) | 3/30/22 | |
| P00008 | Other Administrative Action | ($893) | 3/15/21 | |
| 7 | Exercise an Option | $28.8k | 4/3/17 | |
| 6 | Exercise an Option | $28.8k | 3/31/16 |